Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Advanced Materials Regulatory News (MGAM)

Share Price Information for Morgan Advanced Materials (MGAM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 314.50
Bid: 316.00
Ask: 317.00
Change: -0.50 (-0.16%)
Spread: 1.00 (0.316%)
Open: 314.50
High: 318.50
Low: 314.50
Prev. Close: 315.00
MGAM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement of intention not to make an offer

1 Dec 2014 07:00

RNS Number : 4029Y
Vesuvius plc
01 December 2014
 



NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF THAT JURISDICTION

 

FOR IMMEDIATE RELEASE

 

1 December 2014

STATEMENT OF INTENTION NOT TO MAKE AN OFFER UNDER RULE 2.8 OF THE CITY CODE ONTAKEOVERS AND MERGERS

 

Vesuvius plc ("Vesuvius") today announces that in the course of the past month it made a preliminary proposal to the Board of Morgan Advanced Materials plc ("Morgan") for an all-share merger between the two companies. The proposal was rejected by the Board of Morgan without discussions taking place. As a result Vesuvius confirms that it does not now intend to make an offer for Morgan.

 

The Board of Vesuvius (the "Board") believes that a combination of the two companies would have created a higher margin global leader in advanced ceramics technology, with complementary business models, strategies and cultures, delivering value-enhancing products and technical services to a broad range of end-markets, and would have delivered:

· enhanced opportunities for top-line growth through:

- the ability to deliver stronger and wider offerings to customers;

- the cross-utilisation of combined technologies and R&D capabilities;

 

· substantial recurring cost synergies including:

- significant efficiencies in the purchasing of raw materials;

- cost reduction through the rationalisation of local back offices and manufacturing sites given the extensive geographic overlap;

 

· greater financial strength and scale to:

- support sustainable investment in growth opportunities in existing and new higher margin markets;

- enable a material cash return to shareholders after a merger of the two companies.

The Board therefore believes that a merger would have created a stronger and broader group which would have been even better positioned to compete in the global marketplace. 

 

Vesuvius Chairman, John McDonough CBE, commented:

 

"We are disappointed that the opportunity to explore the creation of significant incremental value for both sets of shareholders has been rejected. However, the Board has a clearly defined growth strategy for Vesuvius and a track record of delivery. In line with that strategy, we will continue to evaluate compelling opportunities to strengthen the group, whilst continuing to exercise firm capital discipline."

 

As a result of this announcement, Vesuvius will, except with the consent of the Panel, be bound by the restrictions contained in Rule 2.8 of the City Code on Takeovers and Mergers (the "Takeover Code"). For the purposes of Rule 2.8, Vesuvius reserves the right to announce an offer or possible offer for Morgan or make or participate in an offer or possible offer for Morgan and / or take any other action permitted pursuant to the Takeover Code within six months of the date of this announcement, in the circumstances described in note 2 to Rule 2.8 of the Takeover Code.

 

 

 

Enquiries:

Vesuvius plc

François Wanecq, Chief Executive +44 (0) 207 822 0000

Chris O'Shea, Chief Financial Officer +44 (0) 207 822 0000

Media enquiries:

MHP Communications 

John Olsen / Tim Rowntree / Jamie Ricketts +44 (0) 203 128 8100/+44 (0) 203 128 8759

 

Website

 

A copy of this announcement will be available at www.Vesuvius.com by no later than 12 noon (London time) on 2 December 2014. 

 

The content of the website referred to in this announcement is not incorporated into and does not form part of this announcement.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
OTTLBLLXZFFZFBQ
Date   Source Headline
1st May 20245:38 pmRNSHolding(s) in Company
24th Apr 20247:00 amRNSCapital Markets Update
5th Apr 202412:55 pmRNSAnnual Financial Report
4th Apr 20241:16 pmRNSDirector/PDMR Shareholding
27th Mar 20244:52 pmRNSDirector/PDMR Shareholding
27th Mar 20244:50 pmRNSDirector/PDMR Shareholding
27th Mar 20244:49 pmRNSDirector/PDMR Shareholding
27th Mar 20244:48 pmRNSDirector/PDMR Shareholding
14th Mar 20249:42 amRNSDirector/PDMR Shareholding
14th Mar 20249:41 amRNSDirector/PDMR Shareholding
13th Mar 202412:10 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSMorgan Advanced Materials Full Year 2023 Results
27th Dec 20237:00 amRNSDirector/PDMR Shareholding
19th Dec 20231:56 pmRNSDirector/PDMR Shareholding
18th Dec 20234:25 pmRNSBlock listing Interim Review
22nd Nov 202310:07 amRNSDirector/PDMR Shareholding
9th Nov 20237:00 amRNSQ3 Trading Update
9th Oct 20234:43 pmRNSDirector/PDMR Shareholding
26th Sep 202312:24 pmRNSDirector/PDMR Shareholding
16th Aug 202311:27 amRNSDirector/PDMR Shareholding
7th Aug 20235:24 pmRNSDirector/PDMR Shareholding
4th Aug 20237:00 amRNSHalf-Year Results for Period Ended 30 June 2023
13th Jul 20234:49 pmRNSDirector/PDMR Shareholding
5th Jul 20234:51 pmRNSDirector/PDMR Shareholding
29th Jun 20235:06 pmRNSResult of AGM
29th Jun 20237:00 amRNSH1 Trading Update
22nd Jun 202311:50 amRNSBlock listing Interim Review
31st May 20233:52 pmRNSDirector/PDMR Shareholding
26th May 20233:28 pmRNSNotice of Annual General Meeting 2023
24th May 20233:59 pmRNSDirector/PDMR Shareholding
11th May 202312:06 pmRNSDirector/PDMR Shareholding
11th May 202312:01 pmRNSDirector/PDMR Shareholding
11th May 202311:59 amRNSDirector/PDMR Shareholding
9th May 20235:59 pmRNSDirector/PDMR Shareholding
4th May 20235:28 pmRNSAnnual Report & Accounts 2022
3rd May 20235:38 pmRNSDirector/PDMR Shareholding
3rd May 20235:28 pmRNSDirector/PDMR Shareholding
28th Apr 20235:45 pmRNSInformation required by DTR 4.1
28th Apr 20237:00 amRNSFull-year results for the period ended 31 Dec 2022
13th Apr 20237:00 amRNSNotification of Full-Year Results
7th Feb 20237:00 amRNSUpdate on Trading and Cyber Security Incident
18th Jan 20237:00 amRNSAppointment of Chair Designate
10th Jan 20237:00 amRNSNotice of Cyber Security Incident
22nd Dec 202211:01 amRNSBlock listing Interim Review
16th Dec 20224:44 pmRNSHolding(s) in Company
6th Dec 20227:00 amRNSAccelerated Pension Contribution
6th Dec 20227:00 amRNSCapital Markets Event
23rd Nov 202210:01 amRNSDirector/PDMR Shareholding
15th Nov 20225:06 pmRNSDirector/PDMR Shareholding
10th Nov 20228:03 amRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.